Closed

National Generic Pharmaceuticals – Project Revive

NHS England

Value
£1.20
Published
20 Aug 2026
Deadline
25 Sept 2026
Procedure
Not stated
Category
33600000 — Pharmaceutical products
Location
London, UKI45, SE1 8UG, United Kingdom
Notice reference
079388-2026

Requirements summary

NHS England is running preliminary market engagement for a National Generic Pharmaceuticals framework called Project Revive, covering three regional groups (DCE/DSW, DLS/DNE, DLN/DNW). The programme aims to reactivate dormant MHRA-approved marketing authorisations and find new supply routes for critical generic medicines, focused on secondary care supply resilience. The contract period is 1 April 2027 to 31 January 2029 (22 months), with an option to extend to a maximum of 48 months, and specific products will be set out in the Invitation to Offer (ITO).

Key requirements

  • Supply of generic pharmaceuticals for NHS secondary care under a framework agreement
  • Reactivation of dormant or not-marketed MHRA-approved marketing authorisations for critical products
  • Coverage of three regional groups: DCE/DSW, DLS/DNE and DLN/DNW
  • Contract period from 1 April 2027 to 31 January 2029 (22 months), extendable to a maximum of 48 months
  • Engagement with preliminary market engagement by 25 September 2026; tender issue moved to 1 October 2026
  • Specific product list to be provided in the ITO

Similar open notices

National Generic Pharmaceuticals – Project Revive — NHS… | ProposAI